Edge Pharma recalls 0.7% Cantharidin Gel-Forming Suspension (10mL vials) due to CGMP deviations. This may affect product safety. Check NDC 05446-0572-03 for affected items.
CGMP Deviations
Edge Pharma is recalling 0.7% Cantharidin Gel-Forming Suspension vials because of manufacturing quality control issues. This recall affects people using the product topically for medical purposes.
The recall is due to CGMP (Current Good Manufacturing Practice) deviations, which means the product may not meet safety and quality standards. This could potentially lead to unsafe use if the product is not properly manufactured.
People who have purchased the 0.7% Cantharidin Gel-Forming Suspension (10mL vials) from Edge Pharma are affected. Those using the product for topical medical treatments are most at risk.
Check for the NDC code 05446-0572-03 on the vial label. The product was sold between June 2021 and March 2022 through various distribution channels.
Look for the NDC code 05446-0572-03 on the vial to confirm if it is affected.
The recall indicates potential manufacturing quality issues, but the official notice does not specify if the product is safe to use.
The recall does not provide specific action steps for affected users, so contact Edge Pharma directly for guidance.
The recall was initiated in June 2021 and ongoing through March 2022 based on the distribution dates listed.
We’ve drafted a message you can send Edge Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0429-2022 — Edge Pharma Edge Pharma Hello, I own a Edge Pharma that is covered by recall D-0429-2022 from Edge Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
